Rankings
▼
Calendar
CYTK Q2 2019 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
CYTK
Cytokinetics, Incorporated
$8B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+14.8% YoY
Gross Profit
-$17M
-236.5% margin
Operating Income
-$27M
-374.3% margin
Net Income
-$32M
-450.0% margin
EPS (Diluted)
$-0.56
QoQ Revenue Growth
-15.7%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$198M
Total Liabilities
$203M
Stockholders' Equity
-$5M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$6M
+14.8%
Gross Profit
-$17M
-$15M
-9.8%
Operating Income
-$27M
-$23M
-14.1%
Net Income
-$32M
-$28M
-16.7%
Revenue Segments
Research And Development
$7M
100%
← FY 2019
All Quarters
Q3 2019 →